Frost and Sullivan Award
NattoPharma ASA and PL Thomas proudly announce that NattoPharmas natural vitamin K2 product, MenaQ7, Read more
PRESSRELEASES
VITAMIN K2 REDUCES WOMENS RISK OF CORONARY HEART DISEASE
The main goal of the study carried out by Gast and colleagues was to investigate the association of Read more
VITAMIN K2 REDUCES WOMENS RISK OF CORONARY HEART DISEASE, SPECIFICALLY AS MENAQUINONES 7, 8, & 9 2009/02/12
The main goal of the study carried out by Gast and colleagues was to investigate the association of dietary vitamin K1 (phylloquinone) and vitamin K2 (menaquinones) intake with the incidence of coronary heart disease (CHD). To examine a possible corr...
MenaQ7, the natural vitamin K2, may be the solution to doctors fear that calcium supplementation may raise the risk of heart attack. 2008/01/17
This is a really interesting publication which shows an upward trend in cardiovascular events when older women are supplemented with calcium," said Anne Bjrnebye Vik, Responsible R&D and Regulatory Affairs, NattoPharma ASA. "As far as we can judge th...
Vitamin K is required to inhibit calcium accumulation in the arteries: New Paper in Thrombosis and Haemostasis 2008/12/03
December 3rd 2008, Lysaker, Norway - A new publication by Schurgers et al., titled Matrix Gla-protein: The calcification inhibitor in need of vitamin K elucidates the pivotal importance of vitamin K in the activation of Matrix Gla Protein (MGP), the ...
Frost and Sullivan 2008/08/22
NattoPharma ASA and PL Thomas proudly announce that NattoPharmas natural vitamin K2 product, MenaQ7, has received the prestigious 2008 Frost & Sullivan Product Innovation of the Year Award in the North American Vitamin market....
